CUSIP: 52635N103
Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
31,378,962
-
Total 13F shares
-
16,171,755
-
Share change
-
+16,155,534
-
Total reported value
-
$361,085,230
-
Price per share
-
$22.33
-
Number of holders
-
54
-
Value change
-
+$360,723,016
-
Number of buys
-
53
Quarterly Holders Quick Answers
What is CUSIP 52635N103?
CUSIP 52635N103 identifies LENZ - LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 52635N103:
Institutional Holders of LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share (LENZ) as of Q1 2024
As of 31 Mar 2024,
LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share (LENZ) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,171,755 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Alpha Wave Global, LP, EcoR1 Capital, LLC, Samsara BioCapital, LLC, SECTORAL ASSET MANAGEMENT INC, 72 Investment Holdings, LLC, Point72 Asset Management, L.P., RTW INVESTMENTS, LP, TANG CAPITAL MANAGEMENT LLC, and BlackRock Inc..
This page lists
54
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.